By Rob Curran
Idexx Laboratories boosted the lower end of its 2023 earnings projection, even as it lowered revenue expectations, as strong demand for its testing and digital-records products allowed it to increase profit margins.
The Westbrook, Maine-based veterinary-technology company now expects 2023 earnings in a range between $9.74 and $9.90 a share, compared to an August estimated range between $9.64 and $9.90 a share.
Idexx reduced its full-year revenue target to a range between $3.635 billion and $3.65 billion from an August estimated range between $3.66 billion and $3.715 billion.
Idexx boosted its 2023 operating margin forecast to a range between 29.6% and 29.8%
Write to Rob Curran at [email protected]
Read the full article here
